|
1）Ito T, Sasano H, Tanaka M, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol. 2010; 45: 234-43
|
|
|
|
2）田中雅夫. 日本膵臓学会膵癌登録委員会：膵癌登録報告2007. 膵臓. 2007; 22: e26-8
|
|
|
|
|
3）DeLellis RA, Lloyd RV, Heitz PU, et al. WHO classification of tumours, pathology and genetics. Tumours of endocrine organs. IARC Press. 2004
|
|
|
|
|
|
4）Bosman FT, Carneiro F, Hruban RH, et al. WHO Classification of Tumors of the Digestive System (World Health Organization Classification of Tumors). IARC Press. 2010
|
|
|
|
|
|
5）Muniraj T, Vignesh S, Shetty S, et al. Pancreatic neuroendocrine tumors. Dis Mon. 2013; 59: 5-19
|
|
|
|
|
|
6）Wang SC, Parekh JR, Zuraek MB, et al. Identification of unknown primary tumors in patients with neuroendocrine liver metastasis. Arch Surg. 2010; 145: 276-80
|
|
|
|
|
|
7）Boukhman MP, Karam JM, Shaver J, et al. Localization of insulinomas. Arch Surg. 1999; 134: 818-22
|
|
|
|
|
|
8）Puli SR, Kalva N, Bechtold ML, et al. Diagnostic accuracy of endoscopic ultrasound in pancreatic neuroendocrine tumors: A systematic review and meta analysis. World J Gastroenterol. 2013; 19(23): 3678-84
|
|
|
|
|
|
9）Ishikawa T, Itoh A, Kawashima H, et al. Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc. 2010; 71(6): 951-9
|
|
|
|
|
|
10）長谷川俊之，肱岡 範，水野伸匡．膵神経内分泌腫瘍- Up date 2011. 膵神経内分泌腫瘍の生検診断．肝胆膵．2011; 8: 293-300
|
|
|
|
|
|
11）De Angelis C, Brizzi RF, Pellicano R. Endoscopic ultrasonography for pancreatic cancer: current and future perspectives. J Gastrointest Oncol. 2013; 4(2): 220-30
|
|
|
|
|
|
12）Ito T, Igarashi H, Jensen RT. Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances. J Gastroenterol. 2012; 47(9): 941-60
|
|
|
|
|
|
13）Falconi M, Bartsch DK, Eriksson B, et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology. 2012; 95(2): 120-34
|
|
|
|
|
|
14）Knigge U, Hansen CP. Surgery for GEP-NETs. Best Pract Res Clin Gastroenterol. 2012; 26(6): 819-31
|
|
|
|
|
|
15）Haugvik SP, Labori KJ, Edwin B, et al. Surgical treatment of sporadic pancreatic neuroendocrine tumors: a stage of the art review. Scientific World Journal. 2012; Dec 10: Epub
|
|
|
|
|
|
16）Hu M, Zhao G, Luo Y, et al. Laparoscopic versus open treatment for benign pancreatic insulinomas: an analysis of 89 cases. Surg Endosc. 2011; 25(12): 3831-7
|
|
|
|
|
|
17）Jensen RT, Cadiot G, Brandi ML, et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012; 95(2): 98-119
|
|
|
|
|
|
18）Triponez F. Impact of lymphadenectomy on survival in surgery for sporadic gastrinoma. Br J Surg. 2012; 99(9): 1234-40
|
|
|
|
|
|
19）今村正之, 粟根雅章, 井上直也, 他. 膵神経内分泌腫瘍(pNET)に対する最近の外科診療. 胆と膵. 2011; 32: 221-6
|
|
|
|
|
|
20）Bettini R, Partelli S, Boninsegna L, et al. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery. 2011; 150: 75-82
|
|
|
|
|
|
21）Haugvik SP, Labori KJ, Waage A, et al. Pancreatic surgery with vascular reconstruction in patients with locally advanced pancreatic neuroendocrine tumors. J Gastrointest Surg. 2013; 17(7): 1224-32. Epub 2013 May 14
|
|
|
|
|
|
22）Norton JA, Harris EJ, Chen Y, et al. Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection. Arch Surg. 2011; 146(6): 724-32
|
|
|
|
|
|
23）Pavel M, Baudin E, Couvelard A, et al. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 2012; 95(2): 157-76
|
|
|
|
|
|
24）Sarmiento JM, Heywood G, Rubin J, et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003; 197: 29-37
|
|
|
|
|
|
25）Pathak S, Dash I, Taylor MR, et al. The surgical management of neuroendocrine tumour hepatic metastases. Eur J Surg Oncol. 2013; 39(3): 224-8
|
|
|
|
|